Interval training (IT) may induce physiological
adaptations superior to those achieved with conventional
moderate-intensity continuous training (MCT) in patients
with coronary artery disease (CAD). Our objectives were
(1) to systematically review studies which have prescribed
IT in CAD, (2) to summarize the findings of this research
including the safety and physiological benefits of IT, and
(3) to identify areas for further investigation. A systematic
review of the literature using computerized databases was
performed. The search yielded two controlled trials and
five randomized controlled trials (RCTs) enrolling 213
participants. IT prescribed in isolation or in combination
with resistance training was shown to induce significant
and clinically important physiological adaptations in cardiac
patients. IT was also shown to improve cardiorespiratory
fitness (e.g. VO2max, VO2AT), endothelial function,
left ventricle morphology and function (e.g. ejection fraction)
to a significantly greater extent when compared with
conventional MCT. No adverse cardiac or other lifethreatening
events occurred secondary to exercise participation
in these studies. However, these findings must be
interpreted with caution, as methodological limitations
were present in all trials reviewed. In conclusion, robustly
designed RCTs with thorough and standardized reporting
are required to determine the risk and benefits of IT in the
broader cardiac patient population. Further research is
required to determine optimal IT protocols for the use in
cardiac rehabilitation programmes, potentially contributing
to novel exercise prescription guidelines for this patient
population